AXQ Capital’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
Other funds holding LXRX
AG
SL
AXQ Capital's LXRX Position: Q3 2026 in Review
AXQ Capital sold out of Lexicon Pharmaceuticals (LXRX) in Q3 2026, closing a stake of 45,727 shares — an estimated $110K sold.
AXQ Capital first reported a position in LXRX in Q1 2026 and held it in 2 quarters. The position peaked at $110K in Q2 2026. 156 funds tracked by Wall St. Rank hold LXRX as of Q3 2026.
- AXQ Capital reported no remaining Lexicon Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- AXQ Capital sold 45,727 Lexicon Pharmaceuticals shares in Q3 2026, an estimated $110K.
- AXQ Capital first reported a position in Lexicon Pharmaceuticals in Q1 2026 and held it in 2 quarters.
- AXQ Capital's Lexicon Pharmaceuticals position peaked at $110K in Q2 2026.
- 156 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2026.
Based on AXQ Capital's 13F filing for Q3 2026, filed 12 Nov 2026.